发明名称 |
Diclofenac topical formulation |
摘要 |
The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis. |
申请公布号 |
US9339552(B2) |
申请公布日期 |
2016.05.17 |
申请号 |
US201514922903 |
申请日期 |
2015.10.26 |
申请人 |
HZNP Limited |
发明人 |
Kisak Ed;Singh Jagat |
分类号 |
A01N37/12;A61K47/38;A61K9/00;A61K31/196;A61K47/20;A61K47/10 |
主分类号 |
A01N37/12 |
代理机构 |
|
代理人 |
|
主权项 |
1. A topical formulation consisting of:
diclofenac sodium present at 2% w/w; DMSO present at 40 to 50% w/w; hydroxypropyl cellulose; ethanol present at 23% to 29% w/w; propylene glycol present at 10% to 12% w/w; and water to make 100% w/w, wherein the topical formulation has a viscosity of 500 to 5000 centipoise, and wherein the formulation has a pH of 4 to 10. |
地址 |
Pembroke BM |